Latest news with #FakeehCareGroup
Zawya
6 days ago
- Business
- Zawya
Saudi: Fakeeh group delivers H1 2025 revenue of $402.4mln, up 13% year-on-year
Dr Soliman Abdel Kader Fakeeh Hospital Company and its Subsidiaries ('Fakeeh Care Group', 'FCG', 'Fakeeh Care', the 'Company' or the 'Group'), a leading fully integrated academic healthcare provider listed on TASI (SYMBOL: 4017 and ISIN code SA562GSHUOH7), announced its financial results[1] for the second quarter ended 30 June 2025. Growth during the quarter was supported by higher patient volumes and a richer case‑mix as activity normalized post‑Ramadan. The total number of patients served reached 465 thousand+ in 2Q‑2025 (+16% YoY), taking 1H‑2025 volumes to ~900 thousand (+8% YoY). Outpatient and inpatient volumes grew 15% and 16%, respectively, in the quarter translating into combined revenue growth of 18%. Pricing and case‑mix tailwinds added support to the average revenue per outpatient visit and inpatient admission contributing 3% YTD on a consolidated revenue level. Jeddah's double‑digit growth was central driver, complemented by accelerating throughput in Riyadh and early activity in Madinah. At the headline level, the Group delivered 2Q‑2025 revenue of SR812 million (+24% YoY) and Net Profit after Zakat of SR68 million (+59% YoY); 1H‑2025 revenue was SR1.51 billion (+13% YoY). Commenting on the Group's performance, FCG's President Dr. Mazen Soliman Fakeeh said: 'In the second quarter of the year, Fakeeh Care Group revenues reached to SR812 million, posting a solid 24% year on year growth thanks to a 16% year‑on‑year growth of patients served and a richer case mix. Jeddah's year-on-year expansion in census and revenue continues to demonstrate the strength of our brand and clinical depth, while Riyadh's disciplined ramp‑up continues to progress—together with the recently opened DSFH Madinah—our geographic reach continues to broaden. Our platform remained a robust earnings engine with Attributable to Shareholders profits reaching SR154 million in the first half (SR82M in 2Q25) or 28% up year-on-year, after absorbing the anticipated start‑up operating losses from ramping facilities —investments that are underpinning our multi‑year growth trajectory. In Riyadh, operational beds increased to 102 (from 71 a year earlier), supporting mid‑30% growth in outpatient and inpatient volumes and a sharp rise in surgical throughput as higher‑complexity services scale. In Madinah, the Group admitted its first patients in the initial 48 beds (of 200 beds) under a disciplined, quality‑first ramp that is expected to build steadily. In Jeddah, the flagship network remained the primary revenue center, sustaining double‑digit volume growth and strong pull‑through across service lines. The Group broke ground on DSFMC Al Zahraa in Jeddah—developed in partnership with Yasser Yousef Naghi Investment Company—a key spoke in the hub‑and‑spoke strategy. The center will bring comprehensive, high‑quality care closer to the community via one‑day surgical suites, a 24/7 emergency department, an integrated diagnostic hub, and key medical specializations. Dr. Mazen Soliman Fakeeh added: 'Our integrated ecosystem—with tertiary hospitals, medical centers, home healthcare, emergency medical services, medical education, technology and retail medical offerings that complete our service continuum—continues to differentiate Fakeeh Care. We continue to invest in our digital infrastructure, embedding tools that optimize patient journeys, enhance resource utilization, and reinforce our value-based care model, elevating patient reported outcomes.' 'Looking ahead, our priorities are clear: drive utilization across our ramping facilities with strategic case mix refinement in Jeddah and Riyadh; execute a disciplined, quality first ramp in Madinah; advance milestones across our growth agenda; and continue embedding digital and data driven workflows that unlock efficiency while elevating care standards. We aim to further broaden our preventative medicine and early intervention offerings, strengthening longitudinal patient engagement. Throughout, we remain disciplined in capital deployment—preserving a conservative balance sheet as we fund expansion and cement the foundation for a highly scalable and sustainably profitable healthcare ecosystem. With a resilient mature platform, a scalable operating model, and a deepening role in the Kingdom's healthcare transformation, we are well positioned to create enduring value for patients, staff, students, shareholders and the broader community.' he concluded. During the quarter, the Group achieved JCI Enterprise Accreditation, becoming the first private healthcare group in the Kingdom to earn system‑wide endorsement—validating governance, safety culture, standardized clinical pathways and enterprise risk systems, and ensuring the quality DNA of the flagship facilities scales consistently as the network grows. In parallel, Fakeeh Emergency Medical Services (MedE) supported the Kingdom's Hajj operations through the mobilization of ambulatory teams and ambulances and the CSR operation of Namira Hospital at peak demand, deepening the Group's partnership with national health authorities and reinforcing its role in serving broader societal needs. Fakeeh Care Group's complete 2Q-2025 Earnings Release with management's analysis of the Company's performance is available for download on © Copyright 2022 The Saudi Gazette. All Rights Reserved. Provided by SyndiGate Media Inc. (
Saudi Gazette
6 days ago
- Business
- Saudi Gazette
Fakeeh group delivers 1H 2025 revenue of SR1.51 billion, up 13% year-on-year
Dr Soliman Abdel Kader Fakeeh Hospital Company and its Subsidiaries ('Fakeeh Care Group', 'FCG', 'Fakeeh Care', the 'Company' or the 'Group'), a leading fully integrated academic healthcare provider listed on TASI (SYMBOL: 4017 and ISIN code SA562GSHUOH7), announced its financial results[1] for the second quarter ended 30 June 2025. Growth during the quarter was supported by higher patient volumes and a richer case‑mix as activity normalized post‑Ramadan. The total number of patients served reached 465 thousand+ in 2Q‑2025 (+16% YoY), taking 1H‑2025 volumes to ~900 thousand (+8% YoY). Outpatient and inpatient volumes grew 15% and 16%, respectively, in the quarter translating into combined revenue growth of 18%. Pricing and case‑mix tailwinds added support to the average revenue per outpatient visit and inpatient admission contributing 3% YTD on a consolidated revenue level. Jeddah's double‑digit growth was central driver, complemented by accelerating throughput in Riyadh and early activity in Madinah. At the headline level, the Group delivered 2Q‑2025 revenue of SR812 million (+24% YoY) and Net Profit after Zakat of SR68 million (+59% YoY); 1H‑2025 revenue was SR1.51 billion (+13% YoY). Commenting on the Group's performance, FCG's President Dr. Mazen Soliman Fakeeh said: 'In the second quarter of the year, Fakeeh Care Group revenues reached to SR812 million, posting a solid 24% year on year growth thanks to a 16% year‑on‑year growth of patients served and a richer case mix. Jeddah's year-on-year expansion in census and revenue continues to demonstrate the strength of our brand and clinical depth, while Riyadh's disciplined ramp‑up continues to progress—together with the recently opened DSFH Madinah—our geographic reach continues to broaden. Our platform remained a robust earnings engine with Attributable to Shareholders profits reaching SR154 million in the first half (SR82M in 2Q25) or 28% up year-on-year, after absorbing the anticipated start‑up operating losses from ramping facilities—investments that are underpinning our multi‑year growth trajectory. In Riyadh, operational beds increased to 102 (from 71 a year earlier), supporting mid‑30% growth in outpatient and inpatient volumes and a sharp rise in surgical throughput as higher‑complexity services scale. In Madinah, the Group admitted its first patients in the initial 48 beds (of 200 beds) under a disciplined, quality‑first ramp that is expected to build steadily. In Jeddah, the flagship network remained the primary revenue center, sustaining double‑digit volume growth and strong pull‑through across service lines. The Group broke ground on DSFMC Al Zahraa in Jeddah—developed in partnership with Yasser Yousef Naghi Investment Company—a key spoke in the hub‑and‑spoke strategy. The center will bring comprehensive, high‑quality care closer to the community via one‑day surgical suites, a 24/7 emergency department, an integrated diagnostic hub, and key medical specializations. Dr. Mazen Soliman Fakeeh added: 'Our integrated ecosystem—with tertiary hospitals, medical centers, home healthcare, emergency medical services, medical education, technology and retail medical offerings that complete our service continuum—continues to differentiate Fakeeh Care. We continue to invest in our digital infrastructure, embedding tools that optimize patient journeys, enhance resource utilization, and reinforce our value-based care model, elevating patient reported outcomes.' 'Looking ahead, our priorities are clear: drive utilization across our ramping facilities with strategic case mix refinement in Jeddah and Riyadh; execute a disciplined, quality first ramp in Madinah; advance milestones across our growth agenda; and continue embedding digital and data driven workflows that unlock efficiency while elevating care standards. We aim to further broaden our preventative medicine and early intervention offerings, strengthening longitudinal patient engagement. Throughout, we remain disciplined in capital deployment—preserving a conservative balance sheet as we fund expansion and cement the foundation for a highly scalable and sustainably profitable healthcare ecosystem. With a resilient mature platform, a scalable operating model, and a deepening role in the Kingdom's healthcare transformation, we are well positioned to create enduring value for patients, staff, students, shareholders and the broader community.' he concluded. During the quarter, the Group achieved JCI Enterprise Accreditation, becoming the first private healthcare group in the Kingdom to earn system‑wide endorsement—validating governance, safety culture, standardized clinical pathways and enterprise risk systems, and ensuring the quality DNA of the flagship facilities scales consistently as the network grows. In parallel, Fakeeh Emergency Medical Services (MedE) supported the Kingdom's Hajj operations through the mobilization of ambulatory teams and ambulances and the CSR operation of Namira Hospital at peak demand, deepening the Group's partnership with national health authorities and reinforcing its role in serving broader societal needs. Fakeeh Care Group's complete 2Q-2025 Earnings Release with management's analysis of the Company's performance is available for download on
Zawya
6 days ago
- Business
- Zawya
Fakeeh Group delivers 1H 2025 revenue of SAR 1.51 bln, up 13% year-on-year
The Group advances hub‑and‑spoke expansion with DSFMC Al Zahraa groundbreaking; disciplined ramp up in Riyadh and Madinah underpin medium‑term growth trajectory Jeddah, KSA: Dr Soliman Abdel Kader Fakeeh Hospital Company and its Subsidiaries ('Fakeeh Care Group', 'FCG', 'Fakeeh Care', the 'Company' or the 'Group'), a leading fully integrated academic healthcare provider listed on TASI (SYMBOL: 4017 and ISIN code SA562GSHUOH7), announces today its financial result for the second quarter ended 30 June 2025. Growth during the quarter was supported by higher patient volumes and a richer case‑mix as activity normalized post‑Ramadan. The total number of patients served reached 465 thousand+ in 2Q‑2025 (+16% YoY), taking 1H‑2025 volumes to ~900 thousand (+8% YoY). Outpatient and inpatient volumes grew 15% and 16%, respectively, in the quarter translating into combined revenue growth of 18%. Pricing and case‑mix tailwinds added support to the average revenue per outpatient visit and inpatient admission contributing 3% YTD on a consolidated revenue level. Jeddah's double‑digit growth was central driver, complemented by accelerating throughput in Riyadh and early activity in Madinah. At the headline level, the Group delivered 2Q‑2025 revenue of SAR 812 million (+24% YoY) and Net Profit after Zakat of SAR 68 million (+59% YoY); 1H‑2025 revenue was SAR 1.51 billion (+13% YoY). Commenting on the Group's performance, FCG's President Dr. Mazen Soliman Fakeeh said: ' In the second quarter of the year, Fakeeh Care Group revenues reached to SAR 812 million, posting a solid 24% year on year growth thanks to a 16% year‑on‑year growth of patients served and a richer case mix. Jeddah's year-on-year expansion in census and revenue continues to demonstrate the strength of our brand and clinical depth, while Riyadh's disciplined ramp‑up continues to progress—together with the recently opened DSFH Madinah—our geographic reach continues to broaden. Our platform remained a robust earnings engine with Attributable to Shareholders profits reaching SAR 154 million in the first half (SAR 82M in 2Q25) or 28% up year-on-year, after absorbing the anticipated start‑up operating losses from ramping facilities investments that are underpinning our multi‑year growth trajectory. In Riyadh, operational beds increased to 102 (from 71 a year earlier), supporting mid‑30% growth in outpatient and inpatient volumes and a sharp rise in surgical throughput as higher‑complexity services scale. In Madinah, the Group admitted its first patients in the initial 48 beds (of 200 beds) under a disciplined, quality‑first ramp that is expected to build steadily. In Jeddah, the flagship network remained the primary revenue center, sustaining double‑digit volume growth and strong pull‑through across service lines. The Group broke ground on DSFMC Al Zahraa in Jeddah developed in partnership with Yasser Yousef Naghi Investment Company a key spoke in the hub‑and‑spoke strategy. The center will bring comprehensive, high‑quality care closer to the community via one‑day surgical suites, a 24/7 emergency department, an integrated diagnostic hub, and key medical specializations. Dr. Mazen Soliman Fakeeh added: 'Our integrated ecosystem with tertiary hospitals, medical centers, home healthcare, emergency medical services, medical education, technology and retail medical offerings that complete our service continuum continues to differentiate Fakeeh Care. We continue to invest in our digital infrastructure, embedding tools that optimize patient journeys, enhance resource utilization, and reinforce our value-based care model, elevating patient reported outcomes.' 'Looking ahead, our priorities are clear: drive utilization across our ramping facilities with strategic case mix refinement in Jeddah and Riyadh; execute a disciplined, quality first ramp in Madinah; advance milestones across our growth agenda; and continue embedding digital and data driven workflows that unlock efficiency while elevating care standards. We aim to further broaden our preventative medicine and early intervention offerings, strengthening longitudinal patient engagement. Throughout, we remain disciplined in capital deployment—preserving a conservative balance sheet as we fund expansion and cement the foundation for a highly scalable and sustainably profitable healthcare ecosystem. With a resilient mature platform, a scalable operating model, and a deepening role in the Kingdom's healthcare transformation, we are well positioned to create enduring value for patients, staff, students, shareholders and the broader community.' he concluded. During the quarter, the Group achieved JCI Enterprise Accreditation, becoming the first private healthcare group in the Kingdom to earn system‑wide endorsement—validating governance, safety culture, standardized clinical pathways and enterprise risk systems, and ensuring the quality DNA of the flagship facilities scales consistently as the network grows. In parallel, Fakeeh Emergency Medical Services (MedE) supported the Kingdom's Hajj operations through the mobilization of ambulatory teams and ambulances and the CSR operation of Namira Hospital at peak demand, deepening the Group's partnership with national health authorities and reinforcing its role in serving broader societal needs. Fakeeh Care Group's complete 2Q-2025 Earnings Release with management's analysis of the Company's performance is available for download on About Fakeeh Care Group Established in 1978 by the late Dr. Soliman Fakeeh, the Fakeeh Care Group stands as a pioneer in integrated healthcare services in Saudi Arabia. Our comprehensive healthcare offering includes our core healthcare services ranging from ambulatory care to secondary and tertiary care, supported by Emergency Medical Services and Fakeeh Home Healthcare. Additionally, our offerings are enhanced by our industry-leading academic healthcare programs. Building on a strong track record of growth in our home city of Jeddah, the Group embarked on a Kingdom-wide expansion strategy to bring our well proven hub-and-spoke model and medical support services to major cities across Saudi Arabia. In June 2024, Fakeeh Care Group successfully concluded its initial public offering (IPO) on the Tadawul. The IPO raised gross proceeds of SAR 2.9 billion (US$ 764 million) for the Company and the Selling Shareholders of which SAR 1.7 billion will be used to support and accelerate the Group's growth strategy. For further information, please contact: Fakeeh Care Group e-mail: investors@
Saudi Gazette
7 days ago
- Health
- Saudi Gazette
A global milestone: Dr. Soliman Fakeeh Hospital in Jeddah receives accreditation for 14 Centers of Excellence from SRC
In a remarkable and unprecedented global achievement that adds to its legacy of excellence, Dr. Soliman Fakeeh Hospital in Jeddah has been awarded accreditation for 14 Centers of Excellence by the Surgical Review Corporation (SRC) across various medical and surgical specialties—setting a world record for the highest number of Centers of Excellence accredited by SRC within a single hospital. This prestigious international recognition reflects the hospital's deep commitment to implementing 10 rigorous global standards, ensuring the delivery of safe, comprehensive, and high-quality patient care. The accredited specialties include: 1. Robotic Surgery 2. Urology 3. Orthopedic Surgery4. Spine Surgery5. Surgery of the Hand6. Colorectal Surgery7. Hernia Surgery8. Plastic Surgery9. Endoscopy10. Ear, Nose & Throat (ENT)11. Ophthalmology12. Minimally Invasive Gynecology13. Specialized Anesthesia in Obesity Surgery14. Specialized Anesthesia in Orthopedic SurgeryThese accreditations are based on the hospital's adherence to ten rigorous global standards developed by SRC for Centers of include institutional commitment with a clear vision and a quality-first culture, certified medical expertise from highly qualified physicians with outstanding surgical records, trusted medical leadership to oversee program efficiency, and comprehensive consultative services with ongoing medical support for all medical and surgical standards include the use of state-of-the-art equipment and advanced technology with fully trained staff, the availability of a qualified and dedicated medical and surgical teams with consistent on-call coverage, the application of standardized clinical pathways with precise protocols to ensure optimal care, and well-trained support teams including program coordinators, nurses, assistants, and specialized surgical education is also prioritized through the provision of clear information and the obtaining of informed consent for all procedures with a shared decision-making approach. There is also a firm commitment to ongoing quality evaluation, outcome monitoring, and full compliance with data protection Mazen Fakeeh, President of Fakeeh Care Group, expressed his pride in this exceptional global achievement, reaffirming the hospital's commitment to delivering specialized, world-class healthcare that meets patients' expectations and supports the vision of Fakeeh Care Group for excellence, leadership, and innovation in worth noting that the Surgical Review Corporation (SRC) is an independent, global, non-profit organization dedicated to accrediting hospitals, surgeons, and surgical centers according to the highest standards of quality and patient Center of Excellence designation is awarded only after a comprehensive and rigorous evaluation process that ensures healthcare services are advanced, safe, and aligned with the best global medical practices.
Argaam
28-04-2025
- Health
- Argaam
Fakeeh Care inks MoU with Fosun Pharma to develop Cell-Gene Therapies
Dr. Soliman Abdel Kader Fakeeh Hospital Co. (Fakeeh Care) and its subsidiaries, Fakeeh Care Group and Fakeeh Care, signed a strategic memorandum of understanding (MoU) with global innovator Shanghai Fosun Pharmaceutical Co. Ltd. to bring advanced cell- and gene-therapy solutions—most notably CAR-T—as well as AI-powered digital pathology and remote diagnostics to the Kingdom. Aligned with Saudi Vision 2030, the partnership seeks to accelerate local development and delivery of cutting-edge treatments, enhance diagnostic accuracy, and establish Saudi Arabia as a regional hub for healthcare innovation, the company said in a statement to Tadawul. Advanced cell and gene therapy solutions, as well as AI-powered digital pathology and remote diagnostic services, will be introduced to the Kingdom of Saudi Arabia, the statement added. The company explained that the MoU was signed on April 27, 2025, and is valid for one year.
